Abstract:Many diseases, as well as side effects of drugs, manifest themselves through skin symptoms. Skin is a complex tissue that hosts various specialized cell types and performs many roles including physical barrier, immune and sensory functions. Therefore, modeling skin in vitro presents technical challenges for tissue engineering. Since the first attempts at engineering human epidermis in 1970s, there has been a growing interest in generating full-thickness skin constructs mimicking physiological functions by incorporating various skin components, such as vasculature and melanocytes for pigmentation. Development of biomimetic in vitro human skin models with these physiological functions provides a new tool for drug discovery, disease modeling, regenerative medicine and basic research for skin biology. This goal, however, has long been delayed by the limited availability of different cell types, the challenges in establishing co-culture conditions, and the ability to recapitulate the 3D anatomy of the skin. Recent breakthroughs in induced pluripotent stem cell (iPSC) technology and microfabrication techniques such as 3D-printing have allowed for building more reliable and complex in vitro skin models for pharmaceutical screening. In this review, we focus on the current developments and prevailing challenges in generating skin constructs with vasculature, skin appendages such as hair follicles, pigmentation, immune response, innervation, and hypodermis. Furthermore, we discuss the promising advances that iPSC technology offers in order to generate in vitro models of genetic skin diseases, such as epidermolysis bullosa and psoriasis. We also discuss how future integration of the next generation human skin constructs onto microfluidic platforms along with other tissues could revolutionize the early stages of drug development by creating reliable evaluation of patient-specific effects of pharmaceutical agents. Impact statement Skin is a complex tissue that hosts various specialized cell types and performs many roles including barrier, immune, and sensory functions. For human-relevant drug testing, there has been a growing interest in building more physiological skin constructs by incorporating different skin components, such as vasculature, appendages, pigment, innervation, and adipose tissue. This paper provides an overview of the strategies to build complex human skin constructs that can faithfully recapitulate human skin and thus can be used in drug development targeting skin diseases. In particular, we discuss recent developments and remaining challenges in incorporating various skin components, availability of iPSC-derived skin cell types and in vitro skin disease models. In addition, we provide insights on the future integration of these complex skin models with other organs on microfluidic platforms as well as potential readout technologies for high-throughput drug screening.

Skin Development and Disease: A Molecular Perspective

Ontogeny of Skin Stem Cells and Molecular Underpinnings

From Molecular Mechanisms to Pathology

Bioengineered skin organoids: from development to applications

Integrative Multiomics Approach to Skin: The Sinergy between Individualised Medicine and Futuristic Precision Skin Care?

Skin Organoid Research Progress and Potential Applications

Exosomes: Emerging Diagnostic and Therapeutic Targets in Cutaneous Diseases

Developmental cell programs are co-opted in inflammatory skin disease

Skin in the game: a review of single-cell and spatial transcriptomics in dermatological research

Unraveling the skin; a comprehensive review of atopic dermatitis, current understanding, and approaches

Exosomes As a Novel Pathway for Regulating Development and Diseases of the Skin (Review)

Development of Physiologically Relevant Skin Organoids from Human Induced Pluripotent Stem Cells

Recent advances in understanding the role of the skin microbiome in the treatment of atopic dermatitis

Next generation human skin constructs as advanced tools for drug development

Molecular and spatial landmarks of early mouse skin development

Skin Immunity and Its Dysregulation in Atopic Dermatitis, Hidradenitis Suppurativa and Vitiligo.

Advances in the human skin microbiota and its roles in cutaneous diseases

The Human Skin Microbiome in Selected Cutaneous Diseases

Immunosenescence and Skin: A State of Art of Its Etiopathogenetic Role and Crucial Watershed for Systemic Implications

The Skin Epilipidome in Stress, Aging, and Inflammation

A human prenatal skin cell atlas reveals immune cell regulation of skin morphogenesis